CITADEL ADVISORS LLC

Holdings History for Lexeo Therapeutics, Inc. - Common Stock ($0.0001 par value) (the "Shares") (LXEO)

Symbol
LXEO on Nasdaq
Investment type
Equity / Common Stock ($0.0001 par value) (the "Shares")
Latest Disclosed Shares Owned
5,498,219 shares
Security Ownership %
7.4%
Shares, Excluding Options vs Price
Value, Excluding Options

Kenneth Griffin ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)

17 Feb 2026 - Kenneth Griffin has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,498,219 shares of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO). This represents 7.4% ownership of the company. In their previous filing dated 14 Aug 2025, CITADEL ADVISORS LLC had reported owning 5,334,112 shares, indicating an increase of +3.1%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.